Sidong Chen

Sidong Chen

Auto-generated profile, based on publicly available information

Sidong Chen

Department of Epidemiology, Public Health College, Guangdong Pharmaceutical University, Guangzhou 510006, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2012 in Cancer Science
Verified
Journal Article
Closed access
PDF file
JCJun‐Jiang Chen
Jun‐Jiang Chen
YSYue‐Li Sun
Yue‐Li Sun
ATAmit K Tiwari
Amit K Tiwari
ZXZhi‐Jie Xiao
Zhi‐Jie Xiao
KSKamlesh Sodani
Kamlesh Sodani
Zhe-Sheng ChenZhe-Sheng Chen
Zhe-Sheng Chen

28 January 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TBTao Bu
Tao Bu
LLLi Liu
Li Liu
YSYong Sun
Yong Sun
LZLi Zhao
Li Zhao
YPYang Peng
Yang Peng
YGYanhui Gao
Yanhui Gao
In the X-ray repair cross-complementing group 1 (XRCC1) gene, a polymorphism, Arg399Gln (rs25487), has been shown to change neoconservative amino acid and thus result in alternation of DNA repair capacity. Numerous studies have investigated the association between Arg399Gln and breast cancer risk in the American population, but yielding inconsistent results. This study aimed to clarify the role of this polymorphism in susceptibility to breast cancer. Literatures were searched in multiple databases including PubMed, Springer Link, Ovid, EBSCO and ScienceDirect databases up to April 2013. A comprehensive meta-analysis was conducted to estimate the overall odds ratio (OR), by integrating data from 18 case control studies of 10846 cases and 11723 controls in the American population. Overall, significant association was observed between the Arg399Gln polymorphism and breast cancer risk under the random-effects model (OR for dominant model = 1.12, 95% CI: 1.02–1.24, Pheterogeneity = 0.003; OR for additive model = 1.07, 95% CI: 1.01–1.14, Pheterogeneity = 0.017). Further sensitivity analysis supported the robust stability of this current result by showing similar ORs before and after removal of a single study. This meta-analysis suggests that the XRCC1 Arg399Gln polymorphism may significantly contribute to susceptibility of breast cancer in the American population.

29 September 2015 in BMC Public Health
Verified
Journal Article
Open access
PDF file
XYXiaohua Ye
Xiaohua Ye
SCSidong Chen
Sidong Chen
ZYZhenjiang Yao
Zhenjiang Yao
YGYanhui Gao
Yanhui Gao
YXYa Xu
Ya Xu
YYYi Yang
Yi Yang
According to the partial smoke-free legislation implemented on 1 September 2010 in Guangzhou, China, smoke-free did not cover all indoor areas. Some places have a full smoking ban (100 % smoke-free), other places have a partial smoking ban, and homes have no ban. This study aimed to compare the smoking behaviors before and after implementation of a smoke-free legislation. A repeated cross-sectional survey was conducted on smoking-related behaviors with a total of 4,900 respondents before, and 5,135 respondents after the legislation was instituted. For each wave of the survey, a three-stage stratified sampling process was used to obtain a representative sample. Pearson’s Chi-square test was used to determine differences of smoking prevalence and quit ratio between the two samples. Logistic regression models were used to examine the associations of a smoke-free legislation with smoking behaviors. The overall daily smoking rate declined significantly from 20.8 % to 18.2 % (p < 0.05), especially among those aged 15–24 years. The quit ratios increased significantly (from 14.5 % to 17.9 %), but remained low among 15–44 year olds. The overall self-reported smoking behaviors in locations with a full smoking ban decreased significantly from 36.4 % to 24.3 % with the greater drops occurring in cultural venues, public transport vehicles, and government offices. Smoking in places with partial smoking bans remained high (89.6 % vs. 90.4 %), although a slight decrease was observed in some of these areas. The implementation of a smoke-free legislation did not lead to more smoking in homes (91.0 % vs 89.4 %), but smoking in homes remained high. These findings highlight the urgent need for a comprehensive smoke-free legislation covering all public places in Guangzhou, simultaneously educational interventions and campaigns promoting voluntary changes in home smoking need to occur.

20 January 2014 in Cancer Epidemiology
Verified
Journal Article
Closed access
LLLi Liu
Li Liu
RZRong Zhong
Rong Zhong
LZLi Zou
Li Zou
JFJinjian Fu
Jinjian Fu
BZBeibei Zhu
Beibei Zhu
XMXiaoping Miao
Xiaoping Miao

17 September 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JCJun-Jiang Chen
Jun-Jiang Chen
APAtish Patel
Atish Patel
KSKamlesh Sodani
Kamlesh Sodani
ZXZhi-Jie Xiao
Zhi-Jie Xiao
ATAmit K Tiwari
Amit K Tiwari
Zhe-Sheng ChenZhe-Sheng Chen
Zhe-Sheng Chen
Natural products are frequently used for adjuvant chemotherapy in cancer treatment. 23-O-(1,4'-bipiperidine-1-carbonyl) betulinic acid (BBA) is a synthetic derivative of 23-hydroxybutulinic acid (23-HBA), which is a natural pentacyclic triterpene and the major active constituent of the root of Pulsatilla chinensis. We previously reported that BBA could reverse P-glycoprotein (P-gp/ABCB1)-mediated multidrug resistance (MDR). In the present study, we investigated whether BBA has the potential to reverse multidrug resistance protein 7 (MRP7/ABCC10)-mediated MDR. We found that BBA concentration-dependently enhanced the sensitivity of MRP7-transfected HEK293 cells to paclitaxel, docetaxel and vinblastine. Accumulation and efflux experiments demonstrated that BBA increased the intracellular accumulation of [3H]-paclitaxel by inhibiting the efflux of [3H]-paclitaxel from HEK293/MRP7 cells. In addition, immunoblotting and immunofluorescence analyses indicated no significant alteration of MRP7 protein expression and localization in plasma membranes after treatment with BBA. These results demonstrate that BBA reverses MRP7-mediated MDR through blocking the drug efflux function of MRP7 without affecting the intracellular ATP levels. Our findings suggest that BBA has the potential to be used in combination with conventional chemotherapeutic agents to augment the response to chemotherapy.

23 January 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
HSHabib Dastmalchi Saei
Habib Dastmalchi Saei
JMJo-Ann McClure
Jo-Ann McClure
AKAyesha Kashif
Ayesha Kashif
SCSidong Chen
Sidong Chen
JCJohn M. Conly
John M. Conly
KZKunyan Zhang
Kunyan Zhang
Staphylococcus aureus sequence type (ST) 398 is a lineage affecting both humans and livestock worldwide. However, the mechanisms underlying its clonal evolution are still not clearly elucidated. We applied whole-genome sequencing (WGS) typing to 45 S. aureus strains from China and Canada between 2005 and 2014, in order to gain insight into their evolutionary pathway. Based on WGS phylogenetic analysis, 42 isolates were assigned to the human-associated clade (I/II-GOI) and 3 isolates to livestock-associated clade (IIa). Phylogeny of ϕSa3 sequences revealed five phage groups (Groups 1–5), with Group 1 carrying ϕSa3-Group 1 (ϕSa3-G1), Group 2 carrying ϕSa3-G2, Group 3 carrying ϕSa3-G3, Group 4 carrying ϕSa3-G4 and Group 5 lacking ϕSa3. ϕSa3-G1 was only found in strains that accounted for the most ancestral human clade I, while ϕSa3-G2, ϕSa3-G3 and ϕSa3-G4 were found restricted to sublineages within clade II-GOI. Some isolates of clade II-GOI were also found to be ϕSa3-negative or resistant to methicillin which are unusual characteristics for human-adapted isolates. This study demonstrated a strong association between phylogenetic grouping and phage type, suggesting an important role of ϕSa3 prophage in the evolution of human-adapted ST398 subclones. In addition, our results suggest that this subclone slowly began to adapt to animal hosts by losing ϕSa3 and acquiring methicillin resistance, which was observed in some strains of human-associated clade II-GOI, an intermediate human to livestock transmission clade.